Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Indian J Occup Environ Med ; 24(1): 30-32, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32435112

RESUMEN

Indoor air quality (IAQ) influences human health, productivity and wellness. Green buildings are believed to have better IAQ. The 'sick building syndrome' (SBS) describes a set of nonspecific symptoms experienced by occupants due to time spent in a building with poor IAQ. Thus this study was undertaken to assess the IAQ in green buildings and compare it with that of conventional buildings. The prevalence of SBS in both types of buildings is also studied. In five pairs of green and conventional buildings measurements of comfort parameters (temperature & relative humidity) and indoor air pollutants using monitors was done. 148 employees which included 84 from green buildings and 64 from conventional buildings were surveyed for SBS using an interviewer-administered questionnaire. The analysis was done using SPSS16 and included Mann Whitney for IAQ pollutant concentrations and Chi-square for the SBS prevalence. Similar indoor air quality was found in both types of buildings. The mean of temperature, CO2 and formaldehyde was statistically lower in green buildings. The SBS prevalence was found to be 38.1% in green buildings and 53.1% in conventional buildings. Thus to conclude the poorly maintained green building does not have any added advantage for occurrence of SBS.

2.
Asian J Psychiatr ; 30: 88-93, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28843143

RESUMEN

BACKGROUND: Schizophrenia is associated with functional challenges for patients; relapses in schizophrenia may lead to increased treatment costs and poor quality of life. OBJECTIVE: This SUSTAIN-I study was conducted to establish psychiatrists' perspective on impact of long-acting injectables (LAIs) antipsychotics on the socio-economic and functional burden of schizophrenia. METHODS: This cross-sectional, survey-based study was conducted in 5 cities in India. Psychiatrists (≥5years of experience) working in clinics, psychiatric, government hospitals and rehabilitation centers were included and administered a specially designed questionnaire to elicit information on their clinical practice and prescription patterns. Perceived treatment costs for LAI versus oral antipsychotic treatments (OATs) and relapse rates were assessed. Descriptive statistics were used to summarize results. RESULTS: Total 31 physicians completed this survey. In acute phase, OAT prescription was higher whereas chronic patients were treated with either OATs or LAIs. Treatment with LAIs was the preferred treatment in 9% of chronic cases. Reduced relapse rates were observed with LAI treatment: 12% patients on LAIs relapsed as compared with 60% patients on OATs. Monthly medication cost for oral medications was lower ($8-$17) than short-acting injectables ($22-$50). For chronic cases, atypical antipsychotics cost (oral: $11.7-25, LAI: $150-167) was higher than typical antipsychotics (oral: $4-5, LAI: $5-25). Of the total expenses incurred, cost for hospital admissions was the largest component (78%). CONCLUSION: Despite enhanced treatment adherence and potential to lower risk of rehospitalizations from relapse, LAIs are not the preferred treatment choice for patients with schizophrenia in India, owing to their perceived high costs.


Asunto(s)
Antipsicóticos/economía , Antipsicóticos/farmacología , Actitud del Personal de Salud , Prescripciones de Medicamentos/estadística & datos numéricos , Evaluación de Resultado en la Atención de Salud/estadística & datos numéricos , Pautas de la Práctica en Medicina/estadística & datos numéricos , Psiquiatría/estadística & datos numéricos , Esquizofrenia/tratamiento farmacológico , Administración Oral , Adolescente , Adulto , Antipsicóticos/administración & dosificación , Estudios Transversales , Preparaciones de Acción Retardada/economía , Preparaciones de Acción Retardada/uso terapéutico , Encuestas de Atención de la Salud/estadística & datos numéricos , Humanos , India , Médicos/estadística & datos numéricos , Recurrencia , Conducta Social , Adulto Joven
3.
J Assoc Physicians India ; 62(1): 66-9, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25327100

RESUMEN

Idiopathic CD4+ T-Lymphocytopenia is a rare immunodeficiency disorder characterised by significantly low absolute CD4 lymphocytes in absence of any viral infections. We present a case of Disseminated Cryptococcosis with Caverno- Oesophageal Fistula in a case of Idiopathic CD4+ T-Lymphocytopenia. 29 year old lady was referred to Institute in view of lung mass not responding to anti-TB treatment. Subsequently patient had developed headache. Radiological evaluation showed presence of ring enhancing lesion in the occipital region. On evaluation with Fibre-optic bronchoscopy, there was no evidence of malignancy or tuberculosis. Sputum showed presence and growth of Cryptococcus neoformans. Patient's investigations were negative for virus infection, with normal immunoglobulin levels. Her CD4 counts were 129 cells/mm3. Patient was treated with injectable antifungals. Patient developed a Caverno-oesophageal fistula which was confirmed on endoscopy and radiology. Patient was managed with percutaneous jejunal feeding (PEJ). Patient improved symptomatically with CD4 count of 475 cells/mm3.


Asunto(s)
Criptococosis/complicaciones , Criptococosis/epidemiología , Cryptococcus neoformans , Fístula Esofágica/diagnóstico por imagen , Fístula del Sistema Respiratorio/diagnóstico por imagen , Linfocitopenia-T Idiopática CD4-Positiva/epidemiología , Adulto , Antifúngicos/administración & dosificación , Fístula Esofágica/etiología , Femenino , Fluconazol/administración & dosificación , Humanos , Lóbulo Occipital/microbiología , Radiografía , Fístula del Sistema Respiratorio/etiología , Esputo/microbiología , Linfocitopenia-T Idiopática CD4-Positiva/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...